The following Covid19 management protocols were developed by Paul Marik, MD, Professor of Medicine and Chief of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School, and others, as members of the Front Line COVID-19 Critical Care Alliance (FLCCC).
A key point is to start prescriptions and supplements as soon as possible after the first sign of Covid19 infection. As with all antiviral medications and supplements, the sooner they are started the better they can prevent viral replication.
NOTE: Ivermectin, Hydroxychloroquine, Nitazoxanide, and other medications and supplements in the FLCCC protocols are not FDA approved for treating Covid19 and are used “off label” for this indication. Off-label prescribing is when a physician gives you a drug that the U.S. Food and Drug Administration (FDA) has approved to treat a condition different than your condition. This practice is legal and common. In fact, one in five prescriptions written today are for off-label use.
NOTE: Avoid taking non-steroidal anti-inflammatory drugs (Ibuprofen, Naproxen, Meloxicam, etc) during Covid19 infections as these drugs increase the risk of developing blood clots.
|How much do I weigh?||What dose does the protocol say?|
|In pounds||In kilos||0.2 mg/kg:||0.3 mg/kg:||0.4 mg/kg:||0.6 mg/kg:|
|70-90||32-41||6-8 mg||10-12 mg||13-16 mg||19-25 mg|
|91-110||41-50||8-10 mg||12-15 mg||17-20 mg||25-30 mg|
|111-130||50-59||10-12 mg||15-18 mg||20-24 mg||30-35 mg|
|131-150||60-68||12-14 mg||18-20 mg||24-27 mg||36-41 mg|
|151-170||69-77||14-15 mg||21-23 mg||27-31 mg||41-46 mg|
|171-190||78-86||16-17 mg||23-26 mg||31-35 mg||47-52 mg|
|191-210||87-95||17-19 mg||26-29 mg||35-38 mg||52-57 mg|
|211-230||96-105||19-21 mg||29-31 mg||38-42 mg||58-63 mg|
|231-250||105-114||21-23 mg||32-34 mg||42-45 mg||63-68 mg|
|251-270||114-123||23-25 mg||34-37 mg||46-49 mg||68-74 mg|
|271-290||123-132||25-26 mg||37-40 mg||49-53 mg||74-79 mg|
|291-310||132-141||26-28 mg||40-42 mg||53-56 mg|